Malaysia buys additional 12.2 million doses of Pfizer-BioNTech COVID-19 vaccine
11 Jan 2021 / 12:38 H.
KUALA LUMPUR, Jan 11 (Reuters) - Malaysia on Monday signed a deal to buy an additional 12.2 million doses of a COVID-19 vaccine manufactured by U.S. and German drugmakers Pfizer and BioNTech, the health ministry said in a statement.
The deal brings the total amount of the Pfizer vaccines procured by Malaysia to 25 million doses, enough to cover 39% of its population, the ministry said. (Reporting by Rozanna Latiff; Editing by Martin Petty)
Did you like this article?
